Uterine fibroids

Uterine fibroids (also called leiomyomas or myomas) are non-cancerous growths of smooth muscle and connective tissue that develop in or on the wall of the uterus. They are extremely common: cumulative incidence reaches 70 to 80% by age 50 in some populations, though only a fraction cause symptoms severe enough to drive treatment. Black women are diagnosed earlier, more often, and with larger fibroids on average than white women.

This is informational, not medical advice. Uterine fibroid diagnosis and treatment require evaluation by a qualified provider.

How uterine fibroids are diagnosed

  • Pelvic examination may detect an enlarged, irregular uterus.
  • Transvaginal ultrasound is the first-line imaging test.
  • MRI offers detailed mapping of size, number, and location, particularly when surgery is being planned.
  • Saline-infusion sonography or hysteroscopy clarifies fibroids that distort the uterine cavity.

Fibroids are classified by location:

  • Submucosal: project into the uterine cavity. Most likely to cause heavy bleeding and fertility issues.
  • Intramural: within the muscle wall. Most common type.
  • Subserosal: project outward from the uterus. Often cause pressure symptoms more than bleeding.
  • Pedunculated: attached by a stalk.

Size ranges from millimeters to fibroids large enough to fill the pelvis.

Common symptoms

Many fibroids are asymptomatic and found incidentally. Symptomatic fibroids commonly present with:

  • Heavy menstrual bleeding (menorrhagia), often with clots.
  • Prolonged periods, lasting over 7 days.
  • Pelvic pressure or fullness.
  • Frequent urination or constipation from pressure on bladder or bowel.
  • Lower back pain.
  • Painful intercourse, depending on fibroid location.
  • Enlarged abdomen with large fibroids.
  • Anemia from chronic blood loss.
  • Fertility or pregnancy complications, particularly with submucosal or large intramural fibroids.

Pain that is sharply cyclical with the period is more typical of adenomyosis or endometriosis, though they often co-occur with fibroids.

The underlying biology

Fibroids arise from a single smooth-muscle cell of the uterine wall that begins to divide abnormally. They are estrogen and progesterone sensitive: they tend to grow during reproductive years, sometimes accelerate in pregnancy, and shrink after menopause. This hormone responsiveness is the basis for most medical therapies, which aim to lower or block ovarian hormone signaling.

Genetic predisposition is strong; first-degree relatives have notably higher risk. Other contributors include early menarche, nulliparity, obesity, and certain dietary patterns, though causation is mixed.

Cycle syncing with uterine fibroids

The standard four-phase model still applies in the sense that ovulation usually continues normally with fibroids, but heavy bleeding and pelvic symptoms reshape what each phase feels like.

Practical adaptations:

  • Plan around bleeding volume, not just bleeding days. A 9-day period with heavy clots is a different recovery profile than a 4-day period.
  • Anemia drags the whole cycle down. Chronic iron loss can mute the "follicular phase lift" and amplify luteal phase fatigue.
  • Mid-cycle pressure symptoms. Bladder and bowel pressure can fluctuate with cyclical bloating; ovulatory week is not automatically a high-energy peak.
  • Hormonal suppression flattens the cycle. Many users move to a hormonal IUD or continuous combined contraceptive, which removes the four-phase pattern entirely.

Treatment angles

Treatment depends on symptom severity, fibroid characteristics, and fertility plans:

  • Watchful waiting for small, asymptomatic fibroids.
  • NSAIDs for pain, tranexamic acid for bleeding volume.
  • Combined hormonal contraceptives or hormonal IUD to reduce bleeding.
  • GnRH agonists or antagonists to shrink fibroids, often as a pre-surgical bridge.
  • Uterine artery embolization as a uterus-sparing radiologic procedure.
  • Myomectomy (surgical removal of fibroids, preserving the uterus).
  • Hysterectomy as the definitive option when fertility is complete.
  • MRI-guided focused ultrasound for select cases.

All of these should be coordinated with a provider.

Uterine fibroids and the menstrual cycle

A few practical implications:

  • Cycles often remain ovulatory and regular, but bleeding can be very heavy.
  • Bleeding patterns can also include intermenstrual spotting from submucosal fibroids.
  • Fibroids typically shrink after menopause, often resolving symptoms.
  • Co-occurrence with adenomyosis and endometriosis is common; pain disproportionate to fibroid size suggests another condition is contributing.

Related reading